Biomarkers for immunotherapy in multiple sclerosis patients

Project leader:
Project members:
Start date: 1. October 2019
End date: 30. September 2023
Funding source: andere Förderorganisation


Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) that is most common in young adult. The disease is due to an autoimmune reaction in which immune cells, which attack foreign pathogens, damage the body's own tissue.  This project aims at identifying biomarkers in the form of gait characteristics in patients with multiple sclerosis which can be used both for the assessment of the current state of the disease and for the prediction of the further course of the disease in the form of relapses.